6279-88-5 Usage
Chemical Group
Carboxylic Acid
A group of compounds with a carboxyl functional group (-COOH).
Derived from
Naphthalene
A polycyclic aromatic hydrocarbon, serving as the base structure for the compound.
Industrial Use
Pharmaceutical Industry
Commonly used as a precursor in the synthesis of various drugs and active pharmaceutical ingredients.
Potential Properties
Anti-inflammatory, Anti-cancer
Has been studied for its possible therapeutic effects in reducing inflammation and combating cancer.
Application in Organic Synthesis
Building Block
Utilized as a fundamental component in the production of other chemicals.
Complexity
Complex Structure
Features a intricate molecular arrangement which contributes to its diverse applications.
Importance
Field of Chemistry and Pharmaceuticals
Due to its structure and applications, the compound holds a significant place in both chemistry and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 6279-88-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,2,7 and 9 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6279-88:
(6*6)+(5*2)+(4*7)+(3*9)+(2*8)+(1*8)=125
125 % 10 = 5
So 6279-88-5 is a valid CAS Registry Number.
6279-88-5Relevant articles and documents
EtAlCl2/2,6-Disubstituted Pyridine-Mediated Carboxylation of Alkenes with Carbon Dioxide
Tanaka, Shinya,Watanabe, Kota,Tanaka, Yuuki,Hattori, Tetsutaro
supporting information, p. 2576 - 2579 (2016/06/15)
α-Arylalkenes and trialkyl-substituted alkenes undergo carboxylation with CO2 in the presence of EtAlCl2 and 2,6-dibromopyridine to afford the corresponding α,β- and/or β,γ-unsaturated carboxylic acids. This reaction is suggested to proceed via the electrophilic substitution of EtAlCl2 with the aid of the base, followed by the carbonation of the resulting ate complex. This reaction can be applied to terminal dialkylalkenes by using a mixture of 2,6-di-tert-butylpyridine and 2,6-dibromopyridine.
3,4-dihydro-2-naphthamide derivatives as selective dopamine D3 ligands
-
Page/Page column 7; 11, (2008/06/13)
The invention relates to 3,4-dihydro-2-naphthamide derivatives of formula (I), pharmaceutical compositions containing them and their therapeutic applications as partial agonists or antagonists of the dopamine D3 receptor for the treatment of neuropsychological disorders.
